Glucuronidation of antitumour therapeutics – detoxification, mechanism of resistance or prodrug formation?

by Anna Mróz, Zofia Mazerska
Published 2015-12-01

Electrochemical and in silico approaches for liver metabolic oxidation of antitumor-active triazoloacridinone C-1305

by Agnieszka Potęga, Dorota Żelaszczyk, Zofia Mazerska
Published 2020-08-01

Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs’ Cytotoxicity, Metabolism...

by Monika Pawłowska, Anna Kwaśniewska, Zofia Mazerska, Ewa Augustin
Published 2020-05-01

Binary Mixtures of Selected Bisphenols in the Environment: Their Toxicity in Relationship to Individual Constituents

by Katarzyna Owczarek, Błażej Kudłak, Vasil Simeonov, Zofia Mazerska, Jacek Namieśnik
Published 2018-12-01

Chiral Pyrazolo[4,3-<i>e</i>][1,2,4]triazine Sulfonamides—Their Biological Activity, Lipophilicity, Protein Affinity, and Metabolic Transformations

by Zofia Bernat, Anna Mieszkowska, Zofia Mazerska, Joanna Matysiak, Zbigniew Karczmarzyk, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
Published 2021-03-01

Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells

by Anna Mieszkowska, Anna M. Nowicka, Agata Kowalczyk, Agnieszka Potęga, Monika Pawłowska, Michał Kosno, Ewa Augustin, Zofia Mazerska
Published 2021-04-01

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells

by Magdalena Niemira, Barbara Borowa-Mazgaj, Samuel B. Bader, Adrianna Moszyńska, Marcin Ratajewski, Kaja Karaś, Mirosław Kwaśniewski, Adam Krętowski, Zofia Mazerska, Ester M. Hammond, Anna Skwarska
Published 2020-08-01